近期骨折患者在骨折联络服务中的健康相关生活质量:3年随访研究
本研究纳入499例近期骨折并就诊于骨折联络服务的患者,采用EQ-5D-5L和SF-6D测量健康状态效用值,随访3年。结果显示3年总体健康相关生活质量变化无统计学意义(P=0.52),但6个月和12个月较基线有显著改善。后续骨折与生活质量显著下降相关。
要点
- 3年总体健康状态效用值变化不显著,但6个月和12个月较基线有轻微显著改善。
- 后续骨折与显著的生活质量损失相关(平均差-0.078,P<0.001)。
- 后续骨折、既往抗骨质疏松药物治疗、 prevalent椎体骨折(2或3级)、使用助行器、既往跌倒和高BMI与较低的平均EQ-5D健康状态效用值负相关。
核心结论
- 3年健康状态效用值变化无统计学意义(P=0.52),但6个月和12个月较基线有显著改善。
- 后续骨折与显著的生活质量损失相关(平均差-0.078,P<0.001)。
- 六个因素与3年平均EQ-5D健康状态效用值负相关。
研究设计与样本
- 研究纳入499例近期骨折并就诊于骨折联络服务的患者,随访3年。
- 健康状态效用值由EQ-5D-5L和SF-6D在六个时间点计算得出,缺失数据采用多重插补。
- 采用线性混合效应回归分析(随机截距和斜率)探索健康状态效用值随时间的変化。
主要发现
- 3年随访期间EQ-5D健康状态效用值变化不显著(P=0.52),但6个月(平均差0.015,P=0.02)和12个月(平均差0.018,P=0.01)较基线有轻微但显著的升高。
- 不同骨折部位间EQ-5D健康状态效用值变化无显著差异(P=0.86)。
- 仅在骨折联络服务就诊与指数骨折间隔较短(<107天)的患者中观察到健康状态效用值显著增加。
- 后续骨折与显著的生活质量损失相关(平均差-0.078,P<0.001)。
- 后续骨折、既往抗骨质疏松药物治疗、 prevalent椎体骨折(2或3级)、使用助行器、既往跌倒和高BMI与3年平均EQ-5D健康状态效用值负相关。
关键数值与推荐
- EQ-5D健康状态效用值6个月较基线平均差0.015(P=0.02),12个月平均差0.018(P=0.01)。
- 后续骨折与生活质量损失的平均差为-0.078(P<0.001)。
- 骨折联络服务就诊与指数骨折间隔<107天的患者健康状态效用值显著增加。
临床怎么用
- 骨折联络服务应关注患者后续骨折的预防,以减少生活质量损失。
- 对于骨折联络服务就诊与指数骨折间隔较长的患者,可能需要更积极的生活质量干预。
- 具有后续骨折、既往抗骨质疏松药物治疗、 prevalent椎体骨折(2或3级)、使用助行器、既往跌倒或高BMI等因素的患者应加强监测和支持。
局限性
- 缺乏骨折后即刻的健康相关生活质量数据。
- 存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This study explored the course of health state utility value over 3 years in patients with a recent fracture attending a Fracture Liaison Service and suggested that the overall change in health-related quality of life was not significant, although significant improvements were observed at 6 and 12 months compared to baseline. INTRODUCTION: To estimate the 3-year health-related quality of life (HRQoL) of patients with a recent fracture presenting at a Fracture Liaison Service (FLS) and to explore factors associated with health state utility value (HSUV). METHODS: Patients' HSUVs were derived from the EQ-5D-5L and SF-6D and calculated at six time points. Multiple imputation was applied for missing data. Linear mixed-effects regression analysis with random intercept and slope was applied to explore the course of HSUV over 3 years. The impact of subsequent fracture and the length of time between FLS visit and patients' index fracture on HSUV were also investigated. A backward stepwise elimination was applied to identify factors associated with HSUV. RESULTS: A total of 499 patients were included. The change of EQ-5D HSUV was not significant over 3-year follow-up (P = 0.52), although slightly but significantly higher HSUV was captured at 6 months (mean difference (MD): 0.015, P = 0.02) and 12 months (MD: 0.018, P = 0.01). There was no significant difference in the course of EQ-5D HSUV between fracture locations (P = 0.86). A significant increase in HSUV was only captured for patients had shorter time period (< 107 days) between FLS visit and their index fracture. Suffering a subsequent fracture was associated with significant QoL loss (MD: - 0.078, P < 0.001). Subsequent fracture, previous treatment with anti-osteoporosis medication, a prevalent vertebral fracture (grade 2 or 3), use of a walking aid, previous falls, and higher BMI were negatively associated with mean EQ-5D HSUV over 3 years. Comparable results were found using SF-6D HSUV. The lack of HRQoL data immediately after fracture and selection bias were two main limitations. CONCLUSION: The 3-year change in HSUV was not statistically significant, although significant improvements were observed at 6 and 12 months in comparison with baseline. Six factors were negatively associated with EQ-5D HSUV.
引用
- Li N, van Oostwaard M, van den Bergh JP, et al. Health-related quality of life of patients with a recent fracture attending a fracture liaison service: a 3-year follow-up study. Osteoporos Int. 2021. PMID: 34671823. doi:10.1007/s00198-021-06204-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。